|
Dr. Love has served as a member of the Santarus board of directors since March 2005. He was appointed President and Chief Executive Officer of Nuvelo, Inc., a biopharmaceutical company, in March 2001, having been appointed President and Chief Operating Officer of Nuvelo in January 2001. He has served as a director of that company since February 2001 and became Chairman of the board of directors in September 2005. He joined Nuvelo from Theravance, Inc. (formerly Advanced Medicine), a biopharmaceutical company, where he served as Senior Vice President of Development from February 1998 to January 2001. Prior to that, he spent six years at Genentech, Inc., a biotechnology company, holding a number of senior management positions in medical affairs and product development. Dr. Love serves on the 29-member California Independent Citizen's Oversight Commission, which oversees the $3 billion allocated to stem cell research authorized by California Proposition 71. Dr. Love holds a B.A. in molecular biology from Haverford College and an M.D. from Yale Medical School.
| 